机构:[1]Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education (MOE), and State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, and Collaborative Innovation Center, Chengdu, PR China[2]Department of Rheumatology and Immunology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu, PR China四川大学华西医院[3]Department of Biology and Biochemistry, Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX, USA[4]Center for Medical Innovation, Department of Biosciences and Nutrition at Novum, Karolinska Institute, Stockholm, Sweden
第一作者机构:[1]Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education (MOE), and State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, and Collaborative Innovation Center, Chengdu, PR China
通讯作者:
推荐引用方式(GB/T 7714):
Zhao Linjie,Hu Hongbo,Gustafsson Jan-Åke,et al.Nuclear Receptors in Cancer Inflammation and Immunity.[J].Trends in immunology.2020,41(2):172-185.doi:10.1016/j.it.2019.12.006.
APA:
Zhao Linjie,Hu Hongbo,Gustafsson Jan-Åke&Zhou Shengtao.(2020).Nuclear Receptors in Cancer Inflammation and Immunity..Trends in immunology,41,(2)
MLA:
Zhao Linjie,et al."Nuclear Receptors in Cancer Inflammation and Immunity.".Trends in immunology 41..2(2020):172-185